Öz
Bisphosphonate-related which is a new entity in dental and medicalliterature, has become to an important partof the literature with a growing number ofreported cases. When we search the literature for bisphosphonate-related jaw necrosis we can find a lot of reports about itspathology, diagnosis, management andprevention but there are many more subjects to search are found. In this review,bisphosphonat-related jaw necrosis anddental management of this subject is evaluated and discussed
Anahtar Kelimeler
Kaynakça
- Coleman RE: Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27: 165, 2001 11. Hellstein JW, Marek CL: Bisphosphonate osteochemonecrosis (Bis-phossy jaw): Is this Phossy jaw of the 21st century?. J Oral Maxillofac Surg 63:682-689, 2005
- Marx RE: Pamidronate (Aredia) and zoldronate (Zometa) induced avascular necrosis of the jaws: a growing epidem- ic. J Oral Maxillofac Surg 61:1115-, 2003
- Badros A, Weikel d, Salama A, Goloubeva O, Schneider a, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T. Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical features and Risk Factors. J Clin Oncol 24:945-952, 2006
- Bamias A, Kastritis E, Bamia C, Moulopoulo L, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnotopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. Osteonecrosis of the Jaw in cancer after treatment with Bisphosphonates: Incidence and Risk Factors. J Clin Oncol 23:8580-8587, 2006
- Marx RE, Sawatari Y, Fortin M, Broumand V: Bisphosphonate-induced (Osteonecrosis/Osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567-1575, 2005 exposed bone
- Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O: Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117:440-1, 2004
- Migliorati CA, Bisphosphonates and oral cavity avascular bone necrosis J Clin Oncol 21: 4253, 2003
- Zarychanski R, Elphee E, Walton P, Johnston J: Osteonecrosis of the jaw associated with pamidronate therapy.
- Am J Hematol 81(1):73-5, 2006
- Carter GD, Gross AN: Bisphosphonates and avascular necrosis of the jaw. Aust Dent J 48:268, 2003
- Schuster MW, Dymek JM: Oral cavity avascular bone necrosis: a newly recognized complication of intravenous (IV) bisphosphonate therapy in cancer patients (abstract 4905). Blood 104(11), 2004
- Lin JH, Russell G, Gertz B: Pharmacokinetics of alen- dronate: an overview. Int J Clin Pract Suppl 101:18-26, 1999
- Pogrel MA: Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 62:391-2, 2004
- Wooltorton E: Patients receiving intravenous bisphospho- nates should avoid invase dental procedures. CMAJ June 1, 2005
- Sarathy AP, Bourgeois Jr SL, Goodell GG: Bisphosphonate-associated osteonecrosis of the jaw and endodontic treatment: two case reports. J Endod 31(10):759-63, 2005
- Hwang D, Wang HL. Medical contraindications to implant therapy: part I: absolute contraindications. Implant Dent. 2006 Dec;15(4):353-60
- Scully C,Madrid C, Bagan J Dental endosseous implants in patients onbisphosphonate therapy. Implant Dent. 2006 Sep;15(3):212-8.
- Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strate- gies for prevention and early recognition. J Am Dent Assoc. 2005 Dec;136(12):1675-81.
Öz
Dental ve tıbbi literatürde yeni bir antiteolarak tanımlanan bifosfonatlara bağlıolarak geliflen çene osteonekrozları, hergeçen gün artan rapor edilmifl vakalarlabirlikte günümüzde literatürde çok önemlibir yer tutar hale gelmifltir. Literatür incelendiğinde bifosfonat kullanımına bağlıgeliflen çene osteonekrozlarının geliflimi,teflhisi, tedavisi ve korunma yollarıhakkında pek çok makalenin yer aldığıancak henüz arafltırılması gereken pek çoknoktanın mevcut olduğu görülmektedir. Buderlemede bifosfonatlara bağlı olarakgeliflen çene osteonekrozları ve konu ileilgili difl hekimliği yaklaflımları ele alınarakdeğerlendirilmifl ve tartıflılmıfltır
Anahtar Kelimeler
Bifosfonat Mandibula Nekrozu Maksilla Nekrozu Dental yaklaşım
Kaynakça
- Coleman RE: Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27: 165, 2001 11. Hellstein JW, Marek CL: Bisphosphonate osteochemonecrosis (Bis-phossy jaw): Is this Phossy jaw of the 21st century?. J Oral Maxillofac Surg 63:682-689, 2005
- Marx RE: Pamidronate (Aredia) and zoldronate (Zometa) induced avascular necrosis of the jaws: a growing epidem- ic. J Oral Maxillofac Surg 61:1115-, 2003
- Badros A, Weikel d, Salama A, Goloubeva O, Schneider a, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T. Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical features and Risk Factors. J Clin Oncol 24:945-952, 2006
- Bamias A, Kastritis E, Bamia C, Moulopoulo L, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnotopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. Osteonecrosis of the Jaw in cancer after treatment with Bisphosphonates: Incidence and Risk Factors. J Clin Oncol 23:8580-8587, 2006
- Marx RE, Sawatari Y, Fortin M, Broumand V: Bisphosphonate-induced (Osteonecrosis/Osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567-1575, 2005 exposed bone
- Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O: Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117:440-1, 2004
- Migliorati CA, Bisphosphonates and oral cavity avascular bone necrosis J Clin Oncol 21: 4253, 2003
- Zarychanski R, Elphee E, Walton P, Johnston J: Osteonecrosis of the jaw associated with pamidronate therapy.
- Am J Hematol 81(1):73-5, 2006
- Carter GD, Gross AN: Bisphosphonates and avascular necrosis of the jaw. Aust Dent J 48:268, 2003
- Schuster MW, Dymek JM: Oral cavity avascular bone necrosis: a newly recognized complication of intravenous (IV) bisphosphonate therapy in cancer patients (abstract 4905). Blood 104(11), 2004
- Lin JH, Russell G, Gertz B: Pharmacokinetics of alen- dronate: an overview. Int J Clin Pract Suppl 101:18-26, 1999
- Pogrel MA: Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 62:391-2, 2004
- Wooltorton E: Patients receiving intravenous bisphospho- nates should avoid invase dental procedures. CMAJ June 1, 2005
- Sarathy AP, Bourgeois Jr SL, Goodell GG: Bisphosphonate-associated osteonecrosis of the jaw and endodontic treatment: two case reports. J Endod 31(10):759-63, 2005
- Hwang D, Wang HL. Medical contraindications to implant therapy: part I: absolute contraindications. Implant Dent. 2006 Dec;15(4):353-60
- Scully C,Madrid C, Bagan J Dental endosseous implants in patients onbisphosphonate therapy. Implant Dent. 2006 Sep;15(3):212-8.
- Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strate- gies for prevention and early recognition. J Am Dent Assoc. 2005 Dec;136(12):1675-81.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Research Article |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Haziran 2007 |
| Yayımlandığı Sayı | Yıl 2007 Cilt: 1 Sayı: 4 |